Get the Daily Brief
Latest Biotech News
AI Designs Novel Antibiotics for Drug-Resistant Infections
Researchers at MIT have leveraged generative artificial intelligence (AI) to design new antibiotics targeting difficult infections caused by drug-resistant Neisseria gonorrhoeae and...
FDA Approves Precigen's Gene Therapy for Rare Respiratory Disease
The U.S. Food and Drug Administration (FDA) granted full and rapid approval to Precigen Inc.'s gene therapy Papzimeos (zopapogene imadenovec) for treating adults with recurrent respiratory...
Breakthrough Imaging Captures Human Embryo Implantation In Real Time
Researchers at the Institute for Bioengineering of Catalonia, collaborating with Dexeus University Hospital, have for the first time captured three-dimensional, real-time images and videos of...
Eli Lilly's Strategy to Raise Drug Prices in Europe
Eli Lilly announced it will significantly increase the list prices of its weight-loss drug Mounjaro across European markets, including a 170% hike in the UK. This move aligns with the Trump...
Biopharma Financing Surges Despite IPO Drought
Biopharma deal activity outside M&As has surged to record levels in the first seven months of 2025, reaching $164 billion, reflecting strong investment despite a continuing drought in IPOs to...
Schrödinger Discontinues CDC7 Inhibitor After Patient Deaths
Schrödinger has halted development of its CDC7 inhibitor SGR-2921, an experimental cancer drug, following two patient deaths in a Phase I trial involving acute myeloid leukemia (AML) and high-risk...
Immune-Stimulating Antibody Shows Promise in Early Cancer Trial
A Phase 1 clinical study published in Cancer Cell highlights a novel Fc-optimized CD40 agonistic antibody delivered intratumorally with promising efficacy in metastatic cancer patients. Among 12...
Advanced AI Tools Revolutionize Drug Discovery and Disease Research
Cutting-edge advances in artificial intelligence are transforming biotechnology research workflows. Innovations include a new technology accelerating biological data generation for AI training...
Neural Prosthetic Decodes Inner Speech for Communication
Neuroscientists have developed an innovative brain-computer interface (BCI) that enables communication through decoding imagined speech. Unlike traditional BCIs requiring attempted speech, this...
FDA Grants Full Approval to Precigen's Gene Therapy for Rare Respiratory Disease
The U.S. Food and Drug Administration (FDA) has granted a swift, full approval to Precigen Inc.'s gene therapy, Papzimeos (zopapogene imadenovec), for treating adults with recurrent respiratory...
Pfizer's Sickle Cell Drug Candidate Falters in Phase 3 Trial
Pfizer announced that inclacumab, a sickle cell disease drug candidate acquired from Global Blood Therapeutics, failed to meet its primary endpoint in a Phase 3 clinical study. The candidate did...
Elysium Therapeutics Develops Longer-Lasting Opioid Overdose Antidote
Elysium Therapeutics is advancing a novel therapeutic approach to address opioid overdose through its Synthetic Opioid Overdose Prevention and Reversal (SOOPR) program. The investigational...
Revolution in Brain-Computer Interfaces Enables Communication via Inner Speech
Researchers have engineered a brain-computer interface (BCI) system that allows users to communicate by decoding neural signals associated with inner speech, rather than attempted speech....
MIT Harnesses AI to Design Antibiotics Against Drug-Resistant Bacteria
Researchers at the Massachusetts Institute of Technology (MIT) have utilized generative artificial intelligence (AI) to design novel antibiotic compounds targeting highly resistant bacteria such...
Schrödinger Halts CDC7 Inhibitor Development After Patient Deaths
Schrödinger has discontinued development of its CDC7 inhibitor drug candidate, SGR-2921, following the deaths of two patients with acute myeloid leukemia (AML) during a phase I dose-escalation...
Eli Lilly Raises Drug Prices in Europe to Lower U.S. Costs
Eli Lilly announced plans to significantly increase the list prices of its drugs, including the weight-loss medication Mounjaro, across European markets such as the United Kingdom. This strategic...
Congress Reinstates Vaccine Safety Task Force Amid Controversy
The U.S. Department of Health and Human Services (HHS) has announced the reinstatement of the long-defunct Task Force on Safer Childhood Vaccines, originally disbanded in 1998. This move follows a...
Cutting-Edge CUT&Tag Modification Enables Transcription Factor Binding Analysis
Scientists at the University of Cologne have innovated on the CUT&Tag chromatin accessibility assay by optimizing buffer salt concentrations, enabling the detection of transcription factor binding...
Breakthrough in Non-Invasive Real-Time Imaging of Human Embryo Implantation
Researchers at the Institute for Bioengineering of Catalonia, in collaboration with Dexeus University Hospital, have successfully recorded, for the first time, the three-dimensional real-time...
HHS Revives Vaccine Safety Panel Amid Controversy
The U.S. Department of Health and Human Services has reinstated the Task Force on Safer Childhood Vaccines, a panel originally disbanded in 1998, aiming to improve vaccine safety and oversight for...